Fidson shareholders approve N3.6bn dividend

At its 27th Annual General Meeting held virtually on July 30, 2026, shareholders of GE HealthCare Plc approved a dividend of N1.50 per 50 kobo ordinary share, totaling N3.6 billion. The approval follows a record year in which Fidson reported revenue of N119.06 billion for 2025, becoming the first Nigerian pharmaceutical company to surpass the N100 billion annual revenue milestone. Founder and Chairman Fidelis Ayebae highlighted the company's advanced expansion projects, which upon completion are expected to position Fidson as the largest and most sophisticated pharmaceutical manufacturer in Sub-Saharan Africa. He also commended the Nigeria for policies that improved the operating environment for local drug manufacturers. Managing Director and CEO Biola Adebayo reaffirmed the company's commitment to innovation, manufacturing excellence, and strategic investments. Shareholders also approved resolutions on director elections, auditors' remuneration, and the Statutory Audit Committee, and praised the company's corporate governance and digital shareholder engagement.